Logo image of VERX

VERTEX INC - CLASS A (VERX) Stock Fundamental Analysis

NASDAQ:VERX - Nasdaq - US92538J1060 - Common Stock - Currency: USD

35.33  +0.47 (+1.35%)

After market: 35.33 0 (0%)

Fundamental Rating

3

VERX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. Both the profitability and financial health of VERX have multiple concerns. VERX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

VERX had positive earnings in the past year.
VERX had a positive operating cash flow in the past year.
In the past 5 years VERX always reported negative net income.
In the past 5 years VERX always reported a positive cash flow from operatings.
VERX Yearly Net Income VS EBIT VS OCF VS FCFVERX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

VERX has a Return On Assets (-3.84%) which is comparable to the rest of the industry.
VERX's Return On Equity of -22.09% is in line compared to the rest of the industry. VERX outperforms 41.49% of its industry peers.
VERX has a better Return On Invested Capital (0.53%) than 63.48% of its industry peers.
Industry RankSector Rank
ROA -3.84%
ROE -22.09%
ROIC 0.53%
ROA(3y)-2.65%
ROA(5y)-4.32%
ROE(3y)-13.31%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
VERX Yearly ROA, ROE, ROICVERX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

VERX's Operating Margin of 0.62% is fine compared to the rest of the industry. VERX outperforms 62.41% of its industry peers.
VERX has a Gross Margin (64.53%) which is in line with its industry peers.
In the last couple of years the Gross Margin of VERX has remained more or less at the same level.
Industry RankSector Rank
OM 0.62%
PM (TTM) N/A
GM 64.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-0.54%
VERX Yearly Profit, Operating, Gross MarginsVERX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VERX is destroying value.
The number of shares outstanding for VERX has been increased compared to 1 year ago.
The number of shares outstanding for VERX has been increased compared to 5 years ago.
The debt/assets ratio for VERX is higher compared to a year ago.
VERX Yearly Shares OutstandingVERX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VERX Yearly Total Debt VS Total AssetsVERX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

VERX has an Altman-Z score of 4.02. This indicates that VERX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.02, VERX is in the better half of the industry, outperforming 63.48% of the companies in the same industry.
A Debt/Equity ratio of 1.67 is on the high side and indicates that VERX has dependencies on debt financing.
The Debt to Equity ratio of VERX (1.67) is worse than 79.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF N/A
Altman-Z 4.02
ROIC/WACC0.05
WACC10.99%
VERX Yearly LT Debt VS Equity VS FCFVERX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.98 indicates that VERX may have some problems paying its short term obligations.
VERX has a worse Current ratio (0.98) than 75.53% of its industry peers.
VERX has a Quick Ratio of 0.98. This is a bad value and indicates that VERX is not financially healthy enough and could expect problems in meeting its short term obligations.
VERX has a Quick ratio of 0.98. This is in the lower half of the industry: VERX underperforms 74.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
VERX Yearly Current Assets VS Current LiabilitesVERX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.61% over the past year.
VERX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.31% yearly.
VERX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.20%.
Measured over the past years, VERX shows a quite strong growth in Revenue. The Revenue has been growing by 15.71% on average per year.
EPS 1Y (TTM)32.61%
EPS 3Y25.31%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)15.2%
Revenue growth 3Y16.15%
Revenue growth 5Y15.71%
Sales Q2Q%12.94%

3.2 Future

VERX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.03% yearly.
VERX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.87% yearly.
EPS Next Y5.87%
EPS Next 2Y14.97%
EPS Next 3Y24.47%
EPS Next 5Y23.03%
Revenue Next Year14.76%
Revenue Next 2Y14.66%
Revenue Next 3Y15.59%
Revenue Next 5Y15.87%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
VERX Yearly Revenue VS EstimatesVERX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
VERX Yearly EPS VS EstimatesVERX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

VERX is valuated quite expensively with a Price/Earnings ratio of 57.92.
VERX's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.53, VERX is valued quite expensively.
A Price/Forward Earnings ratio of 43.82 indicates a quite expensive valuation of VERX.
The rest of the industry has a similar Price/Forward Earnings ratio as VERX.
VERX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 36.71.
Industry RankSector Rank
PE 57.92
Fwd PE 43.82
VERX Price Earnings VS Forward Price EarningsVERX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VERX indicates a somewhat cheap valuation: VERX is cheaper than 61.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 63.29
VERX Per share dataVERX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VERX does not grow enough to justify the current Price/Earnings ratio.
VERX's earnings are expected to grow with 24.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.86
PEG (5Y)N/A
EPS Next 2Y14.97%
EPS Next 3Y24.47%

0

5. Dividend

5.1 Amount

VERX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VERTEX INC - CLASS A

NASDAQ:VERX (7/22/2025, 8:00:01 PM)

After market: 35.33 0 (0%)

35.33

+0.47 (+1.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners109.63%
Inst Owner Change0.04%
Ins Owners6.35%
Ins Owner Change26.99%
Market Cap5.60B
Analysts79.09
Price Target48.22 (36.48%)
Short Float %8.91%
Short Ratio4.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.16%
Min EPS beat(2)7.01%
Max EPS beat(2)9.3%
EPS beat(4)4
Avg EPS beat(4)11.4%
Min EPS beat(4)7.01%
Max EPS beat(4)15.34%
EPS beat(8)7
Avg EPS beat(8)9.6%
EPS beat(12)11
Avg EPS beat(12)12.37%
EPS beat(16)15
Avg EPS beat(16)21.26%
Revenue beat(2)0
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-1.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.84%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)6
Avg Revenue beat(12)0.1%
Revenue beat(16)9
Avg Revenue beat(16)0.49%
PT rev (1m)1.96%
PT rev (3m)-2.24%
EPS NQ rev (1m)0.6%
EPS NQ rev (3m)-2.79%
EPS NY rev (1m)0%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 57.92
Fwd PE 43.82
P/S 8.15
P/FCF N/A
P/OCF 36.11
P/B 27.93
P/tB N/A
EV/EBITDA 63.29
EPS(TTM)0.61
EY1.73%
EPS(NY)0.81
Fwd EY2.28%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.98
OCFY2.77%
SpS4.34
BVpS1.27
TBVpS-1.33
PEG (NY)9.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.84%
ROE -22.09%
ROCE 0.67%
ROIC 0.53%
ROICexc 0.91%
ROICexgc N/A
OM 0.62%
PM (TTM) N/A
GM 64.53%
FCFM N/A
ROA(3y)-2.65%
ROA(5y)-4.32%
ROE(3y)-13.31%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.03%
GM growth 5Y-0.54%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.67
Debt/FCF N/A
Debt/EBITDA 3.8
Cap/Depr 197.33%
Cap/Sales 24.14%
Interest Coverage 250
Cash Conversion 175.54%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 4.02
F-Score4
WACC10.99%
ROIC/WACC0.05
Cap/Depr(3y)135.67%
Cap/Depr(5y)121.89%
Cap/Sales(3y)16.89%
Cap/Sales(5y)14.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.61%
EPS 3Y25.31%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y5.87%
EPS Next 2Y14.97%
EPS Next 3Y24.47%
EPS Next 5Y23.03%
Revenue 1Y (TTM)15.2%
Revenue growth 3Y16.15%
Revenue growth 5Y15.71%
Sales Q2Q%12.94%
Revenue Next Year14.76%
Revenue Next 2Y14.66%
Revenue Next 3Y15.59%
Revenue Next 5Y15.87%
EBIT growth 1Y142.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.81%
EBIT Next 3Y28.57%
EBIT Next 5Y28.3%
FCF growth 1Y-252.96%
FCF growth 3Y-49.75%
FCF growth 5Y-35.88%
OCF growth 1Y91.41%
OCF growth 3Y21.47%
OCF growth 5Y12.25%